Every day at Holden Comprehensive Cancer Center, we cancer specialists and researchers make decisions and recommendations based on facts we don’t like. A patient’s cancer has recurred. A treatment is not working. The patient lacks the gene that would make them eligible for a promising clinical trial. A highly promising research grant is not funded. We can’t ignore the bad news. Instead, we accept it, and do our best despite the bad news.
I recently had a birthday, and have reached the stage in life where some of my peers are starting to talk about phased retirement. In thinking about this for myself, it would be great to be able to spend more time with my family (including my new granddaughter).